AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
What is the latest Revenue of AARTI DRUGS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,529 Cr |
| Mar2024 | ₹2,716 Cr |
| Mar2023 | ₹2,489 Cr |
| Mar2022 | ₹2,155 Cr |
| Mar2021 | ₹1,806 Cr |
How is Revenue of AARTI DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,529 Cr | -6.90 | |
| Mar2024 | ₹2,716 Cr | 9.14 | |
| Mar2023 | ₹2,489 Cr | 15.49 | |
| Mar2022 | ₹2,155 Cr | 19.31 | |
| Mar2021 | ₹1,806 Cr | - | |
Compare Revenue of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,850.1 Cr | 3.2% | 2.6% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 3.2% |
2.6% |
-14.3% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses